Roivant Sciences Ltd.

Ownership Transactions Reported by 25 Insiders

Symbol
ROIV on Nasdaq
Industry
Pharmaceutical Preparations
Location
7 Th Floor, 50 Broadway, London

Insiders trading volume in the past year

Roivant Sciences Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dexcel Pharma Technologies Ltd. 10%+ Owner $1.06B Nov 10, 2022
Vivek Ramaswamy 10%+ Owner $952M -$92.1M -8.82% Nov 13, 2025
SVF Investments (UK) Ltd 10%+ Owner $756M Sep 28, 2023
Sumitomo Chemical Co., Ltd. 10%+ Owner $737M Jun 22, 2023
QVT Financial LP Director by Deputization $365M -$26.3M -6.72% Nov 19, 2025
Daniel Allen Gold Director $365M -$26.3M -6.72% Nov 19, 2025
Keith Manchester Director $365M -$26.3M -6.72% Nov 19, 2025
Matthew Gline CEO, Director $261M +$50K +0.02% Sep 18, 2025
Mayukh Sukhatme Pres&Chief Investment Officer, Director $226M -$15.6M -6.46% Dec 23, 2024
Eric Venker President & Immunovant CEO $153M -$93.8M -38% Nov 20, 2025
Frank Torti President and Vant Chair $151M Jul 30, 2025
Viking Global Investors Lp 10%+ Owner $133M Jun 22, 2023
Viking Global Performance Llc 10%+ Owner $133M Jun 22, 2023
Benjamin Zimmer President, Roivant Health $12.1M Oct 1, 2021
Richard Pulik Cfo $5.91M Nov 20, 2025
Ilan Oren Director $2.1M Oct 20, 2025
James C. Momtazee Director $1.93M Oct 20, 2025
Rakhi Kumar Chief Accounting Officer $1.74M -$2.37M -57.7% Feb 20, 2025
Jennifer Humes Chief Accounting Officer $1.23M Mar 20, 2025
Melissa Epperly Director $861K Oct 20, 2025
Meghan Fitzgerald Director $592K Sep 10, 2025
Andrew Lo Director $540K Sep 15, 2022
Hiroshi Nomura Director Sep 16, 2022
Masayo Tada Director Oct 1, 2021
Patrick Machado Director Oct 1, 2021

Recent Insider Transactions by Companies or Individuals for Roivant Sciences Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.